Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 15, 2003 - Issue 13
93
Views
39
CrossRef citations to date
0
Altmetric
Research Article

The Biopersistence of Canadian Chrysotile Asbestos Following Inhalation

, &
Pages 1247-1274 | Published online: 01 Oct 2008

REFERENCES

  • Agency for Toxic Substances and Disease Registry. 2003. Report on the expert panel on health effects of asbestos and synthetic vitreous fibers: The influence of fiber length. Prepared for: Agency for Toxic Substances and Disease Registry Division of Health Assessment and Consultation Atlanta, GA.
  • Atkinson, R. J. 1973. Chrysotile asbestos: Colloidal silica surfaces in acidified suspensions. I. Colloid Interface Sci. 42:624–628.
  • Bernstein, D. M., and Riego-Sintes, J. M. R. 1999. Methods for the determination of the hazardous prop-erties for human health of man made mineral fibers (MMMF). European Commission Joint Research Centre, Institute for Health and Consumer Protection, Unit: Toxicology and Chemical Substances, European Chemicals Bureau, EUR 18748 EN, April. http://ecb.ei.jrc.it/DOCUMENTS/Testing-Methods/mmmfweb.pdf
  • Bernstein, D. M., Mast, R., Anderson, R., Hesterberg, T. W., Musselman, R., Kamstrup, O., and Hadley, J. 1994. An experimental approach to the evaluation of the biopersistence of respirable synthetic fibers and minerals. Environ. Health Perspect. 102\(suppl. 5):15–18.
  • Bernstein, D. M., Riego-Sintes, J. M., Ersboell, B. K., and Kunert, J. 2001. Biopersistence of synthetic mineral fibers as a predictor of chronic inhalation toxicity in rats. Inhal. Toxicol. 13(10):823–849.
  • Cannon, W. C., Blanton, E. F., and McDonald, K. E. 1983. The flow-past chamber: An improved nose-only exposure system for rodents. Am. Ind. Hyg. Assoc. I. 44(12):923–928.
  • Churg, A. 1994. Deposition and clearance of chrysotile asbestos. Ann. Occup. Hyg. 38(4):625–633.
  • Churg, A., and DePaoli, L. 1988. Clearance of chrysotile asbestos from human lung. Exp. Lung Res. 14:567–574.
  • Cossette, M., and Delvaux, P. 1979. Technical evaluation of chrysotile ore bodies. In Short course in mineralogical techniques of asbestos determination, ed. R. L. Ledoux, Vol. 4, pp. 79–110. Quebec: Mineralogical Association of Canada.
  • Etherington, D. J., Pugh, D., and Silver, I. A. 1981. Collagen degradation in an experimental inflammatory lesion: Studies on the role of the macrophage. Acta Biol. Med. Ger. 40(10-11):1625–1636.
  • Hargreaves, A., and Taylor, W. H. 1946. An x-ray examination of decomposition products of chrysotile (asbestos) and serpentine. Min. Mag. 27:204–216.
  • Hesterberg, T. W., Chase, G., Axten, C., Miiller, W. C., Musselman, R. P., Kamstrup, O., Hadley, J., Morscheidt, C., Bernstein, D. M., and Thevenaz, P. 1998. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol. Appl. Pharmacol. 151(2): 262–275.
  • Hodgson, A. A. 1979. Chemistry and physics of asbestos. In Asbestos: Properties, applications and haz-ards, eds. L. Michaels and S. S. Chissick, pp. 80-81. New York: John Wiley & Sons.
  • Howard, J. K. 1984. Relative cancer risks from exposure to different asbestos fibre types. N. Z. Med. I. 97:646–649.
  • Ilgren, E., and Chatfield, E. 1997. Coalinga fibre-A short, amphibole-free chrysotile, Part 1: Evidence for a lack of fibrogenic activity. Indoor Built Environ. 6:264–276.
  • Ilgren, E., and Chatfield, E. 1998a. Coalinga fibre: A short, amphibole-free chrysotile, Part 3: Lack of biopersistence. Indoor Built Environ. 7:98–109.
  • Ilgren, E., and Chatfield, E. 1998b. Coalinga fibre-A short, amphibole-free chrysotile, Part 2: Evidence for lack of tumourigenic activity. Indoor Built Environ. 7:18–31.
  • Kamstrup, O., Davis, J. M., Ellehauge, A., and Guldberg, M. 1998. The biopersistence and pathogenic-ity of man-made vitreous fibres after short- and long-term inhalation. Ann. Occup. Hyg. 42(3):191–199.
  • Kiyohara, P. K. 1991. Estudo da interface crisotila-cimento Portland em compósitos de fibro-cimento por métodos óptico-eletrônicos. Sao Paulo: Tese de Doutorado, apres. EPUSP.
  • Mast, R. W., McConnell, E. E., Anderson, R., Chevalier, J., Kotin, P., Bernstein, D. M., Thevenaz, P., Glass, L. R., Miiller, W. C., and Hesterberg, T. W. 1995. Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male Fischer 344 rats. Inhal. Toxicol. 7(4):425–467.
  • Matson, S. M. 1994. Glass fibres in simulated lung fluid: Dissolution behavior and analytical require-ments. Ann. Occup. Hyg. 38:857–877.
  • McDonald, J. C. 1998. Mineral fibre persistence and carcinogenicity. Ind. Health 36(4):372–375.
  • McDonald, J. C., and McDonald, A. D. 1997. Chrysotile, tremolite and carcinogenicity. Ann. Occup. Hyg. 41(6):699–705.
  • McDonald, J. C., McDonald, A. D., and Hughes, J. M. 1999. Chrysotile, tremolite and fibrogenicity. Ann. Occup. Hyg. 43(7):439–442.
  • Morgan, A. 1994. The removal of fibres of chrysotile asbestos from lung. Ann. Occup. Hyg. 38(4):643–646.
  • Mossman, B. T., Bignon, J., Corn, M., Seaton, A., and Gee, J. B. L. 1990. Asbestos: Scientific develop-ments and implications for public policy. Science 247:294–301.
  • Muhle, H., Pott, F., Belmann, B., Takenaka, S., and Ziem, U. 1987. Inhalation and injection experi-ments in rats to test the carcinogenicity of MMMF. Ann. Occup. Hyg. 31(48):755–764.
  • Muhle, H., Creutzenberg, O., Bellmann, B., Heinrich, U., and Mermelstein, R. 1990. Dust overload-ing of lungs: Investigations of various materials, species differences, and irreversibility of effects. J. Aerosol Med. 3\(suppl. 1):111–128.
  • Nagy, B., and Bates, T. F. 1952. Stability of chrysotile asbestos. Am. Mineral 37:1055–1058.
  • Oberdorster, G. 1995a. Lung particle overload: Implications for occupational exposures to particles. Regul. Toxicol. Pharmacol. 21(1):123–135.
  • Oberdorster, G. 1995b. The NTP talc inhalation study: A critical appraisal focused on lung particle over-load. Regul. Toxicol. Pharmacol. 21(2):233–241.
  • Oberdorster, G. 2002. Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal. Toxicol. 14(1):29–56.
  • Pott, F., Ziem, U., Reiffer, F. J., Huth, F., Ernst, H., and Mohr, U. 1987. Carcinogenicity studies on fibres, metal compounds, and some other dusts in rats. Exp. Pathol. 32(3):129–152.
  • Rittinghausen, S., Ernst, H., Muhle, H., and Mohr, U. 1992. Atypical malignant mesotheliomas with osseous and cartilaginous differentiation after intraperitoneal injection of various types of mineral fibres in rats. Exp. Toxicol. Pathol. 44(1):55–58.
  • Rodelsperger, K., Woitowitz, H. J., Bruckel, B., Arhelger, R., Pohlabeln, H., and Jockel, K. H. 1999. Dose-response relationship between amphibole fiber lung burden and mesothelioma. Cancer Detect. Prey. 23(3):183–193.
  • Rogers, R. A., Antonini, J. M., Brismar, H., Lai, J., Hesterberg, T. W., Oldmixon, E. H., Thevenaz, P., and Brain, J. D. 1999. In situ microscopic analysis of asbestos and synthetic vitreous fibers re-tained in hamster lungs following inhalation. Environ. Health Perspect. 107(5):367–375.
  • Skinner, H. C. W., Ross, M., and Fronde, C., eds. 1988. Asbestos and other fibrous minerals, Figure 2.3, p. 31. Oxford University Press.
  • Smith, R. W. 1973. Aqueous surface chemistry of asbestos minerals. Cincinnati, OH: National Institute for Occupational Safety and Health. Report PHS-OH-00332, NTIS PB90-100942INZ.
  • StatSoft, Inc. 2003. STATIST/CA [data analysis software system], version 6. www.statsoft.com.
  • Stoeber, W., Flachsbart, H., and Hochrainer, D. 1970. Der Aerodynamische Durchmesser von Latex-aggregaten und Asbestfassern. Staub-Reinh. Luft 30:277–285.
  • Wagner, J. C., Berry, G., Skidmore, J. W., and Pooley, F. D. 1980. The comparative effects of three chrysotiles by injection and inhalation in rats. 1ARC Sci Publ. 30: 363–372.
  • World Health Organization. 1985. Reference methods for measuring airborne man-made mineral fibres (MMMF), WHO/EURO MMMF Reference Scheme prepared by the WHO/EURO Technical Com-mittee for Monitoring and Evaluating Airborne MMMF, Copenhagen.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.